Home
MA

Mo Alavijeh

211
9
5

About Member

Bio

Mo is a science entrepreneur with over 30 years’ experience in the pharmaceutical industry, having responsibilities as wide-ranging as R&D and innovation, business development and strategic alliances at Pharmidex. He was previously head of drug metabolism, DMPK/PD at Vernalis Research, before which he was DMPK team leader at Aventis Pharma (Sanofi). Mo is visiting Professor at University of Hertfordshire and a fellow of the Royal Society of Chemistry (FRSC) and the Royal Society for Medicine (FRSM).

Experience

EF

MANAGEMENT TRAINING

EFMC •

01/2017 – 01/2017 •

Financial Management of European Commission Projects,

UO

Executive Education

University of Cambridge •

01/2014 – 01/2014 •

International Business Growth

HB

Strategic Financial Analysis for Business Evaluation

Harvard Business School •

01/2012 – 01/2012 •

Executive Education

UC

MBI Modules

University College, London •

01/2010 – 01/2010 •

Bioprocess Design & Economic Evaluation

II

Marketing Strategy

Indian Institute of Management Ahmedabad •

01/2009 – 01/2009 •

Executive Education

P(

Chief Operation Officer

Pharmidex (United Kingdom) •

01/2006 – 01/2008 •

R&D

P(

CHIEF SCIENTIFIC OFFICER

Pharmidex (United Kingdom) •

01/2002 – 01/2006 •

R&D

VL

Department Head

Vernalis Ltd •

01/2000 – 01/2002 •

DMPK

SU

Team Leader

Sanofi-Aventis US LLC •

01/1992 – 01/2000 •

DMPK

UC

Research Scientist

University College London Institute of Neurology •

01/1990 – 01/1992 •

Clinical Neurology - TDM

UI

Institute of neurology, Studied for PhD

UCL Institute of Neurology, University College London •

01/1987 – 01/1990 •

Clinical Neurology - TDM

KC

Institue of Psychiatry, MSc

King's College School •

01/1986 – 01/1987 •

Neurochemistry

Mo Alavijeh — Visiting Professor | PharmaCountry